Home › NDC Lookup › RxCUI directory › RxCUI 1722357

Meloxicam 10 MG Oral Capsule — RxCUI 1722357

RxNorm drug concept · Semantic clinical drug
RxCUI 1722357 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1722357
Official nameMeloxicam 10 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped6
Reported Medicaid activity (SDUD)11,836 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Meloxicam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Meloxicam treats pain and inflammation from osteoarthritis and rheumatoid arthritis in adults. It's also approved for juvenile rheumatoid arthritis in children — the oral suspensio...
  • What conditions is meloxicam actually used to treat?
  • Good news — you can take meloxicam with or without food, so whatever is easiest for you works fine. Taking it with a small snack can help if you find it bothers your stomach. It's...
  • Can I take meloxicam with food, and does it matter what time of day I take it?
📖 Read our full Meloxicam guide →

🕸️ Concept Web — How Meloxicam 10 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Meloxicam 10 MG Oral Capsule RxCUI 1722357

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Meloxicam 41493
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vivlodex 1722350
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Meloxicam Oral Capsule 446251
    • Meloxicam Oral Product 1165678
    • Meloxicam Pill 1165679
    • Meloxicam Oral Capsule [Vivlodex] 1722352
    • Vivlodex Oral Product 1722353
    • Vivlodex Pill 1722354
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Meloxicam 10 MG 1722356
    • Meloxicam 10 MG Oral Capsule [Vivlodex] 1722359
    • Meloxicam 10 MG [Vivlodex] 1722358

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Meloxicam 10 MG SCDC · 1722356
  • Meloxicam Oral Capsule SCDF · 446251
  • Meloxicam Oral Product SCDG · 1165678
  • Meloxicam Pill SCDG · 1165679

Brand-Name Concepts

  • Meloxicam 10 MG Oral Capsule [Vivlodex] SBD · 1722359
  • Meloxicam 10 MG [Vivlodex] SBDC · 1722358
  • Meloxicam Oral Capsule [Vivlodex] SBDF · 1722352
  • Vivlodex Oral Product SBDG · 1722353
  • Vivlodex Pill SBDG · 1722354
  • Vivlodex BN · 1722350

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 1722357 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68180-0188-06 30 CAPSULE in 1 BOTTLE (68180-188-06) Meloxicam Lupin Pharmaceuticals, Inc. 2020-12-22
68180-0189-06 30 CAPSULE in 1 BOTTLE (68180-189-06) Meloxicam Lupin Pharmaceuticals, Inc. 2020-12-22
70954-0076-10 30 CAPSULE in 1 BOTTLE (70954-076-10) Meloxicam ANI Pharmaceuticals, Inc. 2021-03-10
70954-0076-20 90 CAPSULE in 1 BOTTLE (70954-076-20) Meloxicam ANI Pharmaceuticals, Inc. 2021-03-10
70954-0077-10 30 CAPSULE in 1 BOTTLE (70954-077-10) Meloxicam ANI Pharmaceuticals, Inc. 2021-03-10
70954-0077-20 90 CAPSULE in 1 BOTTLE (70954-077-20) Meloxicam ANI Pharmaceuticals, Inc. 2021-03-10
Observed labelers: ANI Pharmaceuticals, Inc. (4) · Lupin Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.